Second primary cancer in irradiated stage I testicular seminoma

M. E. Stein, M. Steiner, J. Lachter, I. Kessel, B. Moskovitz, A. Kuten

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The incidence of second primary cancer (SPC) was deteremined in 64 irradiated stage I testicular seminoma patients, treated and followed at the Northern Israel Oncology Center from 1968 to 1988. Seven (11%) patients developed a total of eight second cancers. The cumulative risk for developing second primary cancer at ten, 15 and 20 years following the diagnosis of seminoma was 2.5%, 5.1% and 8.9%, respectively. Two patients developed SPC within the radiation field (urinary bladder, sigmoid colon) and four patients outside the radiation field (bronchogenic cancer, thymoma, malignant melanoma, thyroid cancer). In two patients, who developed lung cancer and testicular seminoma, respectively, scatter dose from the main radiation field could not be excluded as one of the factors contributing to the SPC. Three patients died as a direct result of their SPC. It is concluded that there is a low, but significant risk of solid SPC among patients apparently cured of early stage seminoma. It will be important in future surveillance studies of stage I seminoma to assess the risk of SPC in the non-irradiated patients.

Original languageEnglish (US)
Pages (from-to)672-667
Number of pages6
JournalStrahlentherapie und Onkologie
Volume169
Issue number11
StatePublished - 1993
Externally publishedYes

Fingerprint

Seminoma
Second Primary Neoplasms
Radiation
Thymoma
Sigmoid Colon
Israel
Thyroid Neoplasms
Melanoma
Lung Neoplasms
Urinary Bladder
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Stein, M. E., Steiner, M., Lachter, J., Kessel, I., Moskovitz, B., & Kuten, A. (1993). Second primary cancer in irradiated stage I testicular seminoma. Strahlentherapie und Onkologie, 169(11), 672-667.

Second primary cancer in irradiated stage I testicular seminoma. / Stein, M. E.; Steiner, M.; Lachter, J.; Kessel, I.; Moskovitz, B.; Kuten, A.

In: Strahlentherapie und Onkologie, Vol. 169, No. 11, 1993, p. 672-667.

Research output: Contribution to journalArticle

Stein, ME, Steiner, M, Lachter, J, Kessel, I, Moskovitz, B & Kuten, A 1993, 'Second primary cancer in irradiated stage I testicular seminoma', Strahlentherapie und Onkologie, vol. 169, no. 11, pp. 672-667.
Stein ME, Steiner M, Lachter J, Kessel I, Moskovitz B, Kuten A. Second primary cancer in irradiated stage I testicular seminoma. Strahlentherapie und Onkologie. 1993;169(11):672-667.
Stein, M. E. ; Steiner, M. ; Lachter, J. ; Kessel, I. ; Moskovitz, B. ; Kuten, A. / Second primary cancer in irradiated stage I testicular seminoma. In: Strahlentherapie und Onkologie. 1993 ; Vol. 169, No. 11. pp. 672-667.
@article{8cd51a46c60d406d995973d06fbf7866,
title = "Second primary cancer in irradiated stage I testicular seminoma",
abstract = "The incidence of second primary cancer (SPC) was deteremined in 64 irradiated stage I testicular seminoma patients, treated and followed at the Northern Israel Oncology Center from 1968 to 1988. Seven (11{\%}) patients developed a total of eight second cancers. The cumulative risk for developing second primary cancer at ten, 15 and 20 years following the diagnosis of seminoma was 2.5{\%}, 5.1{\%} and 8.9{\%}, respectively. Two patients developed SPC within the radiation field (urinary bladder, sigmoid colon) and four patients outside the radiation field (bronchogenic cancer, thymoma, malignant melanoma, thyroid cancer). In two patients, who developed lung cancer and testicular seminoma, respectively, scatter dose from the main radiation field could not be excluded as one of the factors contributing to the SPC. Three patients died as a direct result of their SPC. It is concluded that there is a low, but significant risk of solid SPC among patients apparently cured of early stage seminoma. It will be important in future surveillance studies of stage I seminoma to assess the risk of SPC in the non-irradiated patients.",
author = "Stein, {M. E.} and M. Steiner and J. Lachter and I. Kessel and B. Moskovitz and A. Kuten",
year = "1993",
language = "English (US)",
volume = "169",
pages = "672--667",
journal = "Strahlentherapie und Onkologie",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "11",

}

TY - JOUR

T1 - Second primary cancer in irradiated stage I testicular seminoma

AU - Stein, M. E.

AU - Steiner, M.

AU - Lachter, J.

AU - Kessel, I.

AU - Moskovitz, B.

AU - Kuten, A.

PY - 1993

Y1 - 1993

N2 - The incidence of second primary cancer (SPC) was deteremined in 64 irradiated stage I testicular seminoma patients, treated and followed at the Northern Israel Oncology Center from 1968 to 1988. Seven (11%) patients developed a total of eight second cancers. The cumulative risk for developing second primary cancer at ten, 15 and 20 years following the diagnosis of seminoma was 2.5%, 5.1% and 8.9%, respectively. Two patients developed SPC within the radiation field (urinary bladder, sigmoid colon) and four patients outside the radiation field (bronchogenic cancer, thymoma, malignant melanoma, thyroid cancer). In two patients, who developed lung cancer and testicular seminoma, respectively, scatter dose from the main radiation field could not be excluded as one of the factors contributing to the SPC. Three patients died as a direct result of their SPC. It is concluded that there is a low, but significant risk of solid SPC among patients apparently cured of early stage seminoma. It will be important in future surveillance studies of stage I seminoma to assess the risk of SPC in the non-irradiated patients.

AB - The incidence of second primary cancer (SPC) was deteremined in 64 irradiated stage I testicular seminoma patients, treated and followed at the Northern Israel Oncology Center from 1968 to 1988. Seven (11%) patients developed a total of eight second cancers. The cumulative risk for developing second primary cancer at ten, 15 and 20 years following the diagnosis of seminoma was 2.5%, 5.1% and 8.9%, respectively. Two patients developed SPC within the radiation field (urinary bladder, sigmoid colon) and four patients outside the radiation field (bronchogenic cancer, thymoma, malignant melanoma, thyroid cancer). In two patients, who developed lung cancer and testicular seminoma, respectively, scatter dose from the main radiation field could not be excluded as one of the factors contributing to the SPC. Three patients died as a direct result of their SPC. It is concluded that there is a low, but significant risk of solid SPC among patients apparently cured of early stage seminoma. It will be important in future surveillance studies of stage I seminoma to assess the risk of SPC in the non-irradiated patients.

UR - http://www.scopus.com/inward/record.url?scp=0027365549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027365549&partnerID=8YFLogxK

M3 - Article

C2 - 8248844

AN - SCOPUS:0027365549

VL - 169

SP - 672

EP - 667

JO - Strahlentherapie und Onkologie

JF - Strahlentherapie und Onkologie

SN - 0179-7158

IS - 11

ER -